{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:32:26Z","timestamp":1789021946561,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100016469","name":"Takeda Pharmaceuticals International","doi-asserted-by":"publisher","award":["IISR-2020-200005"],"award-info":[{"award-number":["IISR-2020-200005"]}],"id":[{"id":"10.13039\/100016469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016469","name":"Takeda Pharmaceuticals International","doi-asserted-by":"publisher","award":["IISR-2020-200005"],"award-info":[{"award-number":["IISR-2020-200005"]}],"id":[{"id":"10.13039\/100016469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016469","name":"Takeda Pharmaceuticals International","doi-asserted-by":"publisher","award":["IISR-2020-200005"],"award-info":[{"award-number":["IISR-2020-200005"]}],"id":[{"id":"10.13039\/100016469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metabolomics"],"DOI":"10.1007\/s11306-025-02233-3","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T13:32:09Z","timestamp":1740835929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of gangliosides and ceramides as biomarkers for mucopolysaccharidosis type II (hunter syndrome) through untargeted lipidomic analysis"],"prefix":"10.1007","volume":"21","author":[{"given":"Asma","family":"Farjallah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Maranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Auray-Blais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"issue":"1","key":"2233_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ymgme.2010.09.003","volume":"102","author":"C Auray-Blais","year":"2011","unstructured":"Auray-Blais, C., Bh\u00e9rer, P., Gagnon, R., Young, S. P., Zhang, H. H., An, Y., et al. (2011). Efficient analysis of urinary glycosaminoglycans by LC-MS\/MS in mucopolysaccharidoses type I, II and VI. Molecular Genetics and Metabolism, 102(1), 49\u201356. https:\/\/doi.org\/10.1016\/j.ymgme.2010.09.003","journal-title":"Molecular Genetics and Metabolism"},{"key":"2233_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.aca.2016.06.054","volume":"936","author":"C Auray-Blais","year":"2016","unstructured":"Auray-Blais, C., Lavoie, P., Tomatsu, S., Valayannopoulos, V., Mitchell, J. J., Raiman, J., et al. (2016). UPLC-MS\/MS detection of disaccharides derived from glycosaminoglycans as biomarkers of mucopolysaccharidoses. Analytica Chimica Acta, 936, 139\u2013148. https:\/\/doi.org\/10.1016\/j.aca.2016.06.054","journal-title":"Analytica Chimica Acta"},{"issue":"5","key":"2233_CR3","doi-asserted-by":"publisher","first-page":"e2296","DOI":"10.1371\/journal.pone.0002296","volume":"3","author":"J Ausseil","year":"2008","unstructured":"Ausseil, J., Desmaris, N., Bigou, S., Attali, R., Corbineau, S., Vitry, S., et al. (2008). Early neurodegeneration progresses independently of microglial activation by heparan sulfate in the brain of mucopolysaccharidosis IIIB mice. PLOS ONE, 3(5), e2296. https:\/\/doi.org\/10.1371\/journal.pone.0002296","journal-title":"PLOS ONE"},{"issue":"2","key":"2233_CR4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.pcl.2017.11.011","volume":"65","author":"CM Bellettato","year":"2018","unstructured":"Bellettato, C. M., Hubert, L., Scarpa, M., & Wangler, M. F. (2018). Inborn errors of metabolism involving complex molecules: Lysosomal and peroxisomal storage diseases. Pediatric Clinics, 65(2), 353\u2013373. https:\/\/doi.org\/10.1016\/j.pcl.2017.11.011","journal-title":"Pediatric Clinics"},{"key":"2233_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155188","author":"A Bhalla","year":"2020","unstructured":"Bhalla, A., Ravi, R., Fang, M., Arguello, A., Davis, S. S., Chiu, C. L., et al. (2020). Characterization of fluid biomarkers reveals lysosome dysfunction and neurodegeneration in neuronopathic MPS II patients. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms21155188","journal-title":"International Journal of Molecular Sciences"},{"issue":"7","key":"2233_CR6","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.3390\/ijms21072566","volume":"21","author":"B Breiden","year":"2020","unstructured":"Breiden, B., & Sandhoff, K. (2020). Mechanism of secondary ganglioside and lipid accumulation in lysosomal disease. International Journal of Molecular Sciences, 21(7), 2566. https:\/\/doi.org\/10.3390\/ijms21072566","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"2233_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11011-012-9302-1","volume":"27","author":"D Campos","year":"2012","unstructured":"Campos, D., & Monaga, M. (2012). Mucopolysaccharidosis type I: Current knowledge on its pathophysiological mechanisms. Metabolic Brain Disease, 27(2), 121\u2013129. https:\/\/doi.org\/10.1007\/s11011-012-9302-1","journal-title":"Metabolic Brain Disease"},{"issue":"D1","key":"2233_CR8","doi-asserted-by":"publisher","first-page":"D1677","DOI":"10.1093\/nar\/gkad896","volume":"52","author":"MJ Conroy","year":"2024","unstructured":"Conroy, M. J., Andrews, R. M., Andrews, S., Cockayne, L., Dennis, E. A., Fahy, E., et al. (2024). LIPID MAPS: Update to databases and tools for the lipidomics community. Nucleic Acids Research, 52(D1), D1677\u2013D1682. https:\/\/doi.org\/10.1093\/nar\/gkad896","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"2233_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11306-022-01965-w","volume":"19","author":"KM da Silva","year":"2022","unstructured":"da Silva, K. M., van de Lavoir, M., Robeyns, R., Iturrospe, E., Verheggen, L., Covaci, A., & van Nuijs, A. L. (2022). Guidelines and considerations for building multidimensional libraries for untargeted MS-based metabolomics. Metabolomics, 19(1), 4. https:\/\/doi.org\/10.1007\/s11306-022-01965-w","journal-title":"Metabolomics"},{"issue":"12","key":"2233_CR10","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.3390\/ijms21124211","volume":"21","author":"V De Pasquale","year":"2020","unstructured":"De Pasquale, V., Caterino, M., Costanzo, M., Fedele, R., Ruoppolo, M., & Pavone, L. M. (2020). Targeted metabolomic analysis of a mucopolysaccharidosis IIIB mouse model reveals an imbalance of branched-chain amino acid and fatty acid metabolism. International Journal of Molecular Sciences, 21(12), 4211. https:\/\/doi.org\/10.3390\/ijms21124211","journal-title":"International Journal of Molecular Sciences"},{"key":"2233_CR11","doi-asserted-by":"publisher","unstructured":"Donida, B., Marchetti, D. P., Biancini, G. B., Deon, M., Manini, P. R., & da Rosa, H. T. (2015). Oxidative stress and inflammation in mucopolysaccharidosis type IVA patients treated with enzyme replacement therapy. Biochimica et biophysica acta (BBA) - molecular basis of disease. 1852(5), 1012\u20131019. https:\/\/doi.org\/10.1016\/j.bbadis.2015.02.004","DOI":"10.1016\/j.bbadis.2015.02.004"},{"issue":"5","key":"2233_CR12","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s00216-016-0076-x","volume":"409","author":"M Dufresne","year":"2017","unstructured":"Dufresne, M., Guneysu, D., Patterson, N. H., Marcinkiewicz, M. M., Regina, A., Demeule, M., & Chaurand, P. (2017). Multimodal detection of GM2 and GM3 lipid species in the brain of mucopolysaccharidosis type II mouse by serial imaging mass spectrometry and immunohistochemistry. Analytical and Bioanalytical Chemistry, 409(5), 1425\u20131433. https:\/\/doi.org\/10.1007\/s00216-016-0076-x","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"4","key":"2233_CR13","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.ceb.2007.06.003","volume":"19","author":"V Haucke","year":"2007","unstructured":"Haucke, V., & Di Paolo, G. (2007). Lipids and lipid modifications in the regulation of membrane traffic. Current Opinion in Cell Biology, 19(4), 426\u2013435. https:\/\/doi.org\/10.1016\/j.ceb.2007.06.003","journal-title":"Current Opinion in Cell Biology"},{"issue":"3","key":"2233_CR14","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10545-012-9509-7","volume":"36","author":"F Lamari","year":"2013","unstructured":"Lamari, F., Mochel, F., Sedel, F., & Saudubray, J. M. (2013). Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: Toward a new category of inherited metabolic diseases. Journal of Inherited Metabolic Disease, 36(3), 411\u2013425. https:\/\/doi.org\/10.1007\/s10545-012-9509-7","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"4","key":"2233_CR15","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1478-3231.2007.01475.x","volume":"27","author":"M Mar\u00ed","year":"2007","unstructured":"Mar\u00ed, M., & Fern\u00e1ndez-Checa, J. C. (2007). Sphingolipid signalling and liver diseases. Liver International, 27(4), 440\u2013450. https:\/\/doi.org\/10.1111\/j.1478-3231.2007.01475.x","journal-title":"Liver International"},{"issue":"8","key":"2233_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.4155\/bio-2018-0306","volume":"11","author":"I Menkovic","year":"2019","unstructured":"Menkovic, I., Lavoie, P., Boutin, M., & Auray-Blais, C. (2019). Distribution of heparan sulfate and dermatan sulfate in mucopolysaccharidosis type Ii mouse tissues pre- and post-enzyme-replacement therapy determined by Uplc\u2013Ms\/Ms. Bioanalysis, 11(8), 727\u2013740. https:\/\/doi.org\/10.4155\/bio-2018-0306","journal-title":"Bioanalysis"},{"issue":"4","key":"2233_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11306-024-02129-8","volume":"20","author":"S Mires","year":"2024","unstructured":"Mires, S., Sommella, E., Merciai, F., Salviati, E., Caponigro, V., Basilicata, M. G., et al. (2024). Plasma metabolomic and lipidomic profiles accurately classify mothers of children with congenital heart disease: An observational study. Metabolomics, 20(4), 70. https:\/\/doi.org\/10.1007\/s11306-024-02129-8","journal-title":"Metabolomics"},{"key":"2233_CR18","first-page":"gkae253","volume-title":"MetaboAnalyst 6.0: Towards a unified platform for metabolomics data processing, analysis and interpretation","author":"Z Pang","year":"2024","unstructured":"Pang, Z., Lu, Y., Zhou, G., Hui, F., Xu, L., Viau, C., et al. (2024). MetaboAnalyst 6.0: Towards a unified platform for metabolomics data processing, analysis and interpretation (p. gkae253). Nucleic Acids Research."},{"key":"2233_CR19","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/B978-0-444-59565-2.00039-3","volume-title":"Handbook of clinical neurology","author":"MC Patterson","year":"2013","unstructured":"Patterson, M. C. (2013). Chapter 174 - Gangliosidoses. In O. Dulac, M. Lassonde, & H. B. Sarnat (Eds.), Handbook of clinical neurology (pp. 1707\u20131708). Elsevier. https:\/\/doi.org\/10.1016\/B978-0-444-59565-2.00039-3"},{"key":"2233_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-024-04952-y","author":"CV Pinheiro","year":"2024","unstructured":"Pinheiro, C. V., Ribeiro, R. T., Roginski, A. C., Brondani, M., Zemnia\u00e7ak, \u00c2. B., Hoffmann, C. I. H., et al. (2024). Disturbances in mitochondrial bioenergetics and control quality and unbalanced redox homeostasis in the liver of a mouse model of mucopolysaccharidosis type II. Molecular and Cellular Biochemistry. https:\/\/doi.org\/10.1007\/s11010-024-04952-y","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"1","key":"2233_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.12968\/bjon.2016.25.1.22","volume":"25","author":"J Roberts","year":"2016","unstructured":"Roberts, J., Stewart, C., & Kearney, S. (2016). Management of the behavioural manifestations of Hunter syndrome. British Journal of Nursing, 25(1), 22\u201330. https:\/\/doi.org\/10.12968\/bjon.2016.25.1.22","journal-title":"British Journal of Nursing"},{"issue":"2","key":"2233_CR22","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ymgme.2019.08.008","volume":"129","author":"JT Saville","year":"2020","unstructured":"Saville, J. T., & Fuller, M. (2020). Sphingolipid dyshomeostasis in the brain of the mouse model of mucopolysaccharidosis type IIIA. Molecular Genetics and Metabolism, 129(2), 111\u2013116. https:\/\/doi.org\/10.1016\/j.ymgme.2019.08.008","journal-title":"Molecular Genetics and Metabolism"},{"key":"2233_CR23","doi-asserted-by":"publisher","first-page":"572965","DOI":"10.3389\/fnins.2020.572965","volume":"14","author":"S Sipione","year":"2020","unstructured":"Sipione, S., Monyror, J., Galleguillos, D., Steinberg, N., & Kadam, V. (2020). Gangliosides in the brain: Physiology, pathophysiology and therapeutic applications. Frontiers in Neuroscience, 14, 572965. https:\/\/doi.org\/10.3389\/fnins.2020.572965","journal-title":"Frontiers in Neuroscience"},{"issue":"4","key":"2233_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/21678707.2017.1296761","volume":"5","author":"M Stapleton","year":"2017","unstructured":"Stapleton, M., Kubaski, F., Mason, R. W., Yabe, H., Suzuki, Y., Orii, K. E., et al. (2017). Presentation and treatments for mucopolysaccharidosis type II (MPS II; hunter syndrome). Expert Opinion on Orphan Drugs, 5(4), 295\u2013307. https:\/\/doi.org\/10.1080\/21678707.2017.1296761","journal-title":"Expert Opinion on Orphan Drugs"},{"key":"2233_CR25","doi-asserted-by":"publisher","first-page":"839391","DOI":"10.3389\/fcvm.2022.839391","volume":"9","author":"KM Stepien","year":"2022","unstructured":"Stepien, K. M., Bentley, A., Chen, C., Dhemech, M. W., Gee, E., Orton, P., et al. (2022). Non-cardiac manifestations in adult patients with mucopolysaccharidosis. Frontiers in Cardiovascular Medicine, 9, 839391. https:\/\/doi.org\/10.3389\/fcvm.2022.839391","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"4","key":"2233_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.rchipe.2015.10.004","volume":"87","author":"JL Suarez-Guerrero","year":"2016","unstructured":"Suarez-Guerrero, J. L., G\u00f3mez Higuera, P. J. I., Arias Fl\u00f3rez, J. S., & Contreras-Garc\u00eda, G. A. (2016). Mucopolisacaridosis: Caracter\u00edsticas cl\u00ednicas, diagn\u00f3stico y de manejo. Revista Chilena De Pediatr\u00eda, 87(4), 295\u2013304. https:\/\/doi.org\/10.1016\/j.rchipe.2015.10.004","journal-title":"Revista Chilena De Pediatr\u00eda"},{"issue":"1","key":"2233_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11306-024-02195-y","volume":"21","author":"J Sun","year":"2024","unstructured":"Sun, J., Peters, M., Yu, L. R., Vijay, V., Bidarimath, M., Agrawal, M., et al. (2024). Untargeted metabolomics and lipidomics in COVID-19 patient plasma reveals disease severity biomarkers. Metabolomics, 21(1), 3. https:\/\/doi.org\/10.1007\/s11306-024-02195-y","journal-title":"Metabolomics"},{"key":"2233_CR28","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/978-1-4684-1200-0_34","volume-title":"Ganglioside structure, function, and biomedical potential","author":"K Suzuki","year":"1984","unstructured":"Suzuki, K. (1984). Gangliosides and disease: A review. In R. W. Ledeen, R. K. Yu, M. M. Rapport, & K. Suzuki (Eds.), Ganglioside structure, function, and biomedical potential (pp. 407\u2013418). Springer. https:\/\/doi.org\/10.1007\/978-1-4684-1200-0_34"},{"key":"2233_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cca.2017.09.024","volume":"475","author":"A Tebani","year":"2017","unstructured":"Tebani, A., Schmitz-Afonso, I., Abily-Donval, L., H\u00e9ron, B., Piraud, M., Ausseil, J., et al. (2017). Urinary metabolic phenotyping of mucopolysaccharidosis type I combining untargeted and targeted strategies with data modeling. Clinica Chimica Acta, 475, 7\u201314. https:\/\/doi.org\/10.1016\/j.cca.2017.09.024","journal-title":"Clinica Chimica Acta"},{"issue":"2","key":"2233_CR30","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3390\/ijms20020446","volume":"20","author":"A Tebani","year":"2019","unstructured":"Tebani, A., Abily-Donval, L., Schmitz-Afonso, I., Piraud, M., Ausseil, J., Zerimech, F., et al. (2019). Analysis of mucopolysaccharidosis type VI through integrative functional metabolomics. International Journal of Molecular Sciences, 20(2), 446. https:\/\/doi.org\/10.3390\/ijms20020446","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"2233_CR31","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3390\/jcm9020396","volume":"9","author":"GM Viana","year":"2020","unstructured":"Viana, G. M., Priestman, D. A., Platt, F. M., Khan, S., Tomatsu, S., & Pshezhetsky, A. V. (2020). Brain pathology in mucopolysaccharidoses (MPS) patients with neurological forms. Journal of Clinical Medicine, 9(2), 396. https:\/\/doi.org\/10.3390\/jcm9020396","journal-title":"Journal of Clinical Medicine"},{"issue":"4","key":"2233_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.semcdb.2004.03.002","volume":"15","author":"SU Walkley","year":"2004","unstructured":"Walkley, S. U. (2004). Secondary accumulation of gangliosides in lysosomal storage disorders. Seminars in Cell & Developmental Biology, 15(4), 433\u2013444. https:\/\/doi.org\/10.1016\/j.semcdb.2004.03.002","journal-title":"Seminars in Cell & Developmental Biology"},{"issue":"4","key":"2233_CR33","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10545-014-9710-y","volume":"37","author":"B Winchester","year":"2014","unstructured":"Winchester, B. (2014). Lysosomal diseases: Diagnostic update. Journal of Inherited Metabolic Disease, 37(4), 599\u2013608. https:\/\/doi.org\/10.1007\/s10545-014-9710-y","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"D1","key":"2233_CR34","doi-asserted-by":"publisher","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","volume":"50","author":"DS Wishart","year":"2022","unstructured":"Wishart, D. S., Guo, A., Oler, E., Wang, F., Anjum, A., Peters, H., et al. (2022). HMDB 5.0: The human metabolome database for 2022. Nucleic Acids Research, 50(D1), D622\u2013D631. https:\/\/doi.org\/10.1093\/nar\/gkab1062","journal-title":"Nucleic Acids Research"},{"issue":"6","key":"2233_CR35","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nprot.2011.319","volume":"6","author":"J Xia","year":"2011","unstructured":"Xia, J., & Wishart, D. S. (2011). Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nature Protocols, 6(6), 743\u2013760. https:\/\/doi.org\/10.1038\/nprot.2011.319","journal-title":"Nature Protocols"},{"key":"2233_CR36","unstructured":"Younger, D. S. (2014). 11 Chapter neurologic hereditary metabolic diseases of infancy and childhood. Motor disorders, (pp. 165)."},{"issue":"7","key":"2233_CR37","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1373\/clinchem.2010.161141","volume":"57","author":"H Zhang","year":"2011","unstructured":"Zhang, H., Young, S. P., Auray-Blais, C., Orchard, P. J., Tolar, J., & Millington, D. S. (2011). Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography\u2013tandem mass spectrometry. Clinical Chemistry, 57(7), 1005\u20131012. https:\/\/doi.org\/10.1373\/clinchem.2010.161141","journal-title":"Clinical Chemistry"},{"issue":"6","key":"2233_CR38","doi-asserted-by":"publisher","first-page":"354","DOI":"10.5114\/reum.2014.47228","volume":"52","author":"Z \u017buber","year":"2014","unstructured":"\u017buber, Z., Jurecka, A., Kr\u00f3l-Zdechlikiewicz, A., R\u00f3\u017cd\u017cy\u0144ska-\u015awi\u0105tkowska, A., & Tylki-Szyma\u0144ska, A. (2014). Bone metabolism in patients with mucopolysaccharidosis type II. Rheumatology, 52(6), 354\u2013361. https:\/\/doi.org\/10.5114\/reum.2014.47228","journal-title":"Rheumatology"}],"container-title":["Metabolomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-025-02233-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11306-025-02233-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-025-02233-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T05:19:51Z","timestamp":1745039991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11306-025-02233-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["2233"],"URL":"https:\/\/doi.org\/10.1007\/s11306-025-02233-3","relation":{},"ISSN":["1573-3890"],"issn-type":[{"value":"1573-3890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"13 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"(A) Farjallah has received a research salary for her work during this project. C. Auray-Blais has received grants from Takeda Pharmaceutical International AG, as well as honoraria for lectures given from Sanofi Genzyme, BioMarin Pharmaceuticals Inc., Protalix Biotherapeutics, Amicus Therapeutics, Avrobio, and traveling expenses from Waters Corp. for lectures given. She has received service agreements from Moderna Therapeutics, Sigilon Therapeutics, and 4D Molecular Therapeutics. R. Giugliani received investigator grant, and\/or consulting fees and\/or speaker honoraria from Alexion, Allievex, Alnylam, Amicus, Astellas, Azafaros, BioMarin, Chiesi, Cyclo, JCR, Novartis, Paradigm, PassageBio, Pfizer, PTC, RegenxBio, Sanofi, Takeda and Ultragenyx. (B) Maranda is the medical director at MendeliKABS Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"35"}}